Company Name : Orchid Chemicals & Pharmaceuticals Ltd
Address : ‘Orchid Towers’, #313, Valluvar Kottam High Road, Nungambakkam, Chennai – 600 034, Tamil Nadu, India
Tel No: 91 – 44 – 2821 1000 / 2823 0000
Email : corporate@orchidpharma.com
Website : http://www.orchidpharma.com/
Company Profile
Established in 1992 as an export-oriented unit (EOU), Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. We today rank among the top 15 pharmaceutical companies in India and enjoy a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardio vascular segment (CVS), nutraceuticals and other oral and sterile products. Our pharmaceutical solutions include active pharmaceutical ingredients (API), finished dosage forms, new drug discovery (NDD), novel drug delivery systems (NDDS) and contract research and manufacturing services (CRAMS). We are globally present across 70+ countries through alliances, joint ventures and partnerships with globally reputed majors.
Our integrated business model enables us to cater to business opportunities throughout the value chain, from research to delivery of drugs across therapeutic segments. Our niche product basket helps us maintain an edge over our peers in the markets where we are present. In the years to come, driven by a highly competent and motivated team, we will move from strength to strength in the key domains of API, global generics and drug discovery.
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…